Stockscreener 앱 받기
1.27
0.78%
-0.01
시간 외 거래:
1.26
-0.01
-0.79%
전일 마감가:
$1.28
열려 있는:
$1.28
하루 거래량:
1.11M
Relative Volume:
0.97
시가총액:
$242.77M
수익:
$156.37M
순이익/손실:
$-37.49M
주가수익비율:
-6.0476
EPS:
-0.21
순현금흐름:
$-47.77M
1주 성능:
-8.63%
1개월 성능:
-14.19%
6개월 성능:
-32.09%
1년 성능:
-37.75%
1일 변동 폭
$1.255
$1.315
1주일 범위
$1.255
$1.41
52주 변동 폭
$1.12
$2.54
Cerus Corp Stock (CERS) Company Profile
명칭
Cerus Corp
전화
(925) 288-6000
주소
1220 CONCORD AVENUE, CONCORD, CA
CERS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
1.27 | 244.69M | 156.37M | -37.49M | -47.77M | -0.21 |
|
ABT
Abbott Laboratories
|
127.29 | 219.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.41 | 155.22B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
377.79 | 150.09B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.34 | 115.62B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.33 | 46.52B | 5.69B | 4.15B | 623.10M | 6.95 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-12 | 개시 | Craig Hallum | Buy |
| 2023-01-20 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-01-17 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-10-08 | 재개 | BTIG Research | Buy |
| 2020-06-16 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-02-26 | 개시 | BTIG Research | Buy |
| 2019-11-13 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-08-28 | 개시 | Stifel | Buy |
| 2019-08-23 | 재개 | Stephens | Overweight |
| 2018-01-05 | 재개 | Cantor Fitzgerald | Overweight |
| 2017-12-08 | 재개 | BTIG Research | Neutral |
| 2016-07-07 | 재개 | Cantor Fitzgerald | Buy |
| 2015-12-17 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2014-05-02 | 재확인 | MLV & Co | Buy |
| 2013-04-24 | 재확인 | Cantor Fitzgerald | Buy |
| 2013-03-15 | 재확인 | MLV & Co | Buy |
| 2012-04-17 | 개시 | Cantor Fitzgerald | Buy |
| 2012-02-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2011-11-10 | 재확인 | MLV & Co | Buy |
| 2011-06-03 | 개시 | Wedbush | Outperform |
| 2011-03-04 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2010-03-09 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2009-08-26 | 업그레이드 | Avondale | Mkt Perform → Mkt Outperform |
모두보기
Cerus Corp 주식(CERS)의 최신 뉴스
Published on: 2025-08-01 02:01:44 - Newser
When is Cerus Corporation stock expected to show significant growthRetirement Planning Forecasts For Consistent Profits - jammulinksnews.com
Why Cerus Corporation stock attracts strong analyst attentionFree High Accuracy Alerts for ROI Traders - Newser
Using R and stats models for Cerus Corporation forecastingTechnical Entry Plan with Risk Minimization - Newser
Is it time to cut losses on Cerus CorporationSwing Trading Plan With Smart Signals in Review - metal.it
Understanding Cerus Corporation’s price movementPortfolio Allocation Strategy for Stability - Newser
What makes Cerus Corporation stock price move sharplyReal-Time Investment Picks with Accuracy - Newser
What are analysts’ price targets for Cerus Corporation in the next 12 monthsAI Powered Updates From AI Tools - jammulinksnews.com
Key External Factors That Drive Cerus Corporation Stock Price MovementsFree Stock Market Analysis Courses - Newser
Is Cerus Corporation Stock a Good Fit for Conservative InvestorsDaily Breakout Picks - Newser
Cerus Corporation Stock Analysis and ForecastFree Market Dynamics Reports - PrintWeekIndia
What drives Cerus Corporation stock priceFree Stock Market Mentorship - Autocar Professional
How Cerus Corporation stock performs during market volatilityDouble Profit With Half Risk - Newser
What analysts say about Cerus Corporation stockConsistent triple returns - Autocar Professional
Is Cerus Corporation a good long term investmentSuperior trading gains - jammulinksnews.com
Cerus Earnings: Q2 2025 Results and Investor Call Scheduled for August 5 After Market Close - Stock Titan
Cerus stock rises after securing additional $7.2 million DoD contract By Investing.com - Investing.com Canada
Cerus stock rises after securing additional $7.2 million DoD contract - Investing.com
Cerus receives $7.2 million DoD contract amendment for trauma treatment - Investing.com
Cerus Secures $7.2M DoD Contract to Advance Breakthrough Trauma Treatment Study - Stock Titan
Cerus Q4 2024 slides: Positive EBITDA achieved amid 15% revenue growth - Investing.com Canada
Cerus Q4 2024 slides: Positive EBITDA achieved amid 15% revenue growth By Investing.com - Investing.com South Africa
Cerus Leads The Pack Of 3 Promising Penny Stocks - Yahoo Finance
Cerus advances European regulatory review for INTERCEPT RBC system - Investing.com
Cerus Appoints New Chair Following Board Retirement - TipRanks
Daily Market Movement: Cerus Corp (CERS) Sees a 6.82 Increase, Closing at 1.41 - DWinneX
26,884 Shares in Cerus Co. (NASDAQ:CERS) Purchased by Pallas Capital Advisors LLC - Defense World
Cerus Corporation Celebrates World Blood Donor Day 2025 - Yahoo Finance
Cerus at Goldman Sachs Conference: Pathogen Reduction Leadership - Investing.com
Cerus at Goldman Sachs Conference: Pathogen Reduction Leadership By Investing.com - Investing.com Canada
Cerus Corp shareholders approve equity plan amendment By Investing.com - Investing.com South Africa
Cerus Corp shareholders approve equity plan amendment - Investing.com
Sigyn Therapeutics (OTCMKTS:SIGY) & Cerus (NASDAQ:CERS) Head to Head Comparison - Defense World
Two Sigma Investments LP Acquires 326,605 Shares of Cerus Co. (NASDAQ:CERS) - Defense World
Mackenzie Financial Corp Acquires 17,704 Shares of Seanergy Maritime Holdings Corp. (NASDAQ:SHIP) - Defense World
3 Promising Penny Stocks With Market Caps Over $90M - Yahoo Finance
Cerus Management Takes Stage at Goldman Sachs Healthcare Conference: Key Updates Coming June 11 - Stock Titan
Cantor Fitzgerald maintains Cerus stock rating due to regulatory approvals By Investing.com - Investing.com South Africa
Cantor Fitzgerald maintains Cerus stock rating due to regulatory approvals - Investing.com
Cerus to present new INTERCEPT Blood System data at ISBT Congress - Investing.com
Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan - Yahoo Finance
Cerus (CERS) Gains French and Swiss Regulatory Approvals for New Device | CERS Stock News - GuruFocus
Cerus Corp (CERS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.21%
0.17%
자본화:
|
볼륨(24시간):